Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Rallybio
RLYB
$25.1M
| $91K | ﹤0.01% |
+13,800
| New | +$91K |
|
|
ATIP
3652
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $91K | ﹤0.01% |
5,952
+874
| +17% | +$13.4K |
|
3653
Oriental Culture Holding
OCG
$81.7M
| $90K | ﹤0.01% |
35,940
-13,280
| -27% | -$33.3K |
|
3654
Capricor Therapeutics
CAPR
$289M
| $89K | ﹤0.01% |
23,021
+12,821
| +126% | +$49.6K |
|
3655
ReTo Eco-Solutions
RETO
$13.8M
| $89K | ﹤0.01% |
22
-7
| -24% | -$28.3K |
|
|
AUTL
3656
Autolus Therapeutics
AUTL
$381M
| $88K | ﹤0.01% |
46,300
+21,100
| +84% | +$40.1K |
|
3657
AEye
LIDR
$106M
| $88K | ﹤0.01% |
+6,130
| New | +$88K |
|
3658
Comstock
LODE
$138M
| $88K | ﹤0.01% |
32,021
+27,506
| +609% | +$75.6K |
|
|
SUPV
3659
Grupo Supervielle
SUPV
$548M
| $88K | ﹤0.01% |
+40,900
| New | +$88K |
|
3660
ESSA Pharma
EPIX
$9.72M
| $87K | ﹤0.01% |
34,624
-151,286
| -81% | -$380K |
|
3661
Moleculin Biotech
MBRX
$11.4M
| $87K | ﹤0.01% |
5,480
-153
| -3% | -$2.43K |
|
3662
Vicarious Surgical
RBOT
$33.7M
| $87K | ﹤0.01% |
+1,433
| New | +$87K |
|
|
VIOT
3663
Viomi Technology
VIOT
$226M
| $87K | ﹤0.01% |
81,264
-4,100
| -5% | -$4.39K |
|
|
WKEY
3664
WISeKey
WKEY
$58.9M
| $87K | ﹤0.01% |
19,620
-720
| -4% | -$3.19K |
|
|
MAAS
3665
Maase Inc. Class A Ordinary Shares
MAAS
$887M
| $87K | ﹤0.01% |
190
-69
| -27% | -$31.6K |
|
|
OKUR
3666
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.8M
| $87K | ﹤0.01% |
3,720
-580
| -13% | -$13.6K |
|
3667
Reviva Pharmaceuticals
RVPH
$30.1M
| $86K | ﹤0.01% |
+20,300
| New | +$86K |
|
3668
Stagwell
STGW
$1.44B
| $86K | ﹤0.01% |
13,900
-61,400
| -82% | -$380K |
|
|
BIOC
3669
DELISTED
Biocept, Inc.
BIOC
| $86K | ﹤0.01% |
5,410
-203
| -4% | -$3.23K |
|
3670
NanoViricides
NNVC
$23M
| $85K | ﹤0.01% |
76,973
+5,907
| +8% | +$6.52K |
|
|
TMQ
3671
Trilogy Metals
TMQ
$332M
| $85K | ﹤0.01% |
154,758
-81,263
| -34% | -$44.6K |
|
|
SNCE
3672
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $85K | ﹤0.01% |
10,267
+5,252
| +105% | +$43.5K |
|
3673
EyePoint Pharmaceuticals
EYPT
$934M
| $84K | ﹤0.01% |
+24,000
| New | +$84K |
|
3674
Soluna Holdings
SLNH
$21.1M
| $84K | ﹤0.01% |
12,823
+6,667
| +108% | +$43.7K |
|
|
RNLX
3675
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $84K | ﹤0.01% |
45,000
-81,002
| -64% | -$151K |
|